The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4685
Abstract: Prognostic indicators based on the initial prostate‐specific antigen (PSA) levels, nadir PSA, and time to PSA nadir were calculated to evaluate prognosis after primary androgen deprivation therapy (PADT), as these have been reported in very… read more here.
Keywords: prostate specific; prostate; specific antigen; primary androgen ... See more keywords
Metformin use and hospital attendance‐related resources utilization among diabetic patients with prostate cancer on androgen deprivation therapy: A population‐based cohort study
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5651
Abstract: Androgen deprivation therapy (ADT), used increasingly in the treatment of prostate cancer (PCa), negatively influences glycemic control in diabetes and is associated with an increased risk of diabetes complications where hospitalization commonly ensues. Metformin could… read more here.
Keywords: prostate cancer; deprivation therapy; androgen deprivation; resources utilization ... See more keywords
Effects of long‐term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30320
Abstract: Many men with prostate cancer (PC) require long‐term androgen deprivation therapy (ADT), but to the authors' knowledge, its effects on cognitive function beyond 1 year are not described. read more here.
Keywords: long term; prostate cancer; men prostate; cancer ... See more keywords
Improving bone health in men with prostate cancer receiving androgen deprivation therapy: Results of a randomized phase 2 trial
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31171
Abstract: Strategies to improve bone health care in men receiving androgen deprivation therapy (ADT) are not consistently implemented. The authors conducted a phase 2 randomized controlled trial of 2 education‐based models‐of‐care interventions to determine their feasibility… read more here.
Keywords: receiving androgen; bone health; bone; deprivation therapy ... See more keywords
Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: Preliminary findings
Sign Up to like & getrecommendations! Published in 2020 at "Cancer"
DOI: 10.1002/cncr.33397
Abstract: Increases in fatigue, depressive symptomatology, and cognitive impairment are common after the initiation of androgen deprivation therapy (ADT) for prostate cancer. To date, no studies have examined the potential role of inflammation in the development… read more here.
Keywords: symptomatology; prostate cancer; deprivation therapy; cancer ... See more keywords
Assessing salivary matrix metalloproteinase‐8 in prostate cancer patients undergoing androgen deprivation therapy
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dental Research"
DOI: 10.1002/cre2.624
Abstract: Matrix metalloproteinase‐8 (MMP‐8) is considered as one of the most promising diagnostic markers for periodontal disease. Androgen deprivation therapy (ADT) has been correlated with impaired collagen synthesis and an increase in periodontal tissue susceptibility to… read more here.
Keywords: androgen deprivation; matrix metalloproteinase; deprivation therapy;
Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31346
Abstract: Although androgen deprivation therapy (ADT) is a standard treatment for metastatic prostate cancer, this disease inevitably recurs and progresses to ADT‐resistant stage after this therapy. Accordingly, understanding the mechanism of resistance to ADT and finding… read more here.
Keywords: notch; inhibition notch; notch pathway; therapy ... See more keywords
Long-term prognostic impact of cardiovascular comorbidities in patients with prostate cancer receiving androgen deprivation therapy: A population-based competing risk analysis.
Sign Up to like & getrecommendations! Published in 2023 at "International journal of cancer"
DOI: 10.1002/ijc.34557
Abstract: Our study investigated how adverse cardiovascular outcomes are impacted by cardiovascular comorbidities in patients with prostate cancer treated by androgen deprivation therapy (ADT). Using prospective, population-based data, all Hong Kong patients with prostate cancer who… read more here.
Keywords: comorbidities patients; prostate cancer; cardiovascular comorbidities; androgen deprivation ... See more keywords
Population‐based estimate of the use of intermittent androgen deprivation therapy in prostate cancer patients in Catalonia, Spain
Sign Up to like & getrecommendations! Published in 2019 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4744
Abstract: To estimate the use of intermittent androgen deprivation (IAD) therapy in patients with prostate cancer (PCa). read more here.
Keywords: intermittent androgen; prostate cancer; use intermittent; estimate use ... See more keywords
The impact of hegemonic masculine ideals on self‐esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT‐naïve patients
Sign Up to like & getrecommendations! Published in 2022 at "Psycho-Oncology"
DOI: 10.1002/pon.6001
Abstract: Androgen deprivation therapy (ADT) for Prostate Cancer (PCa) is associated with side effects that could lead to negative body image and low masculine self‐esteem of survivors. We compared a group of PCa survivors following ADT… read more here.
Keywords: therapy adt; self esteem; prostate cancer; masculine ... See more keywords
Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-020-05830-1
Abstract: Androgen deprivation therapy (ADT) is a treatment used in men with prostate cancer (PCa); however it is responsible for many adverse effects, with negative impact on quality of life. ADT causes loss of bone mineral… read more here.
Keywords: androgen deprivation; accidental falls; bone; cancer ... See more keywords